\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ fully\\ alert\\ and\\ oriented\\.\\ his\\ neurological\\ exam\\ revealed\\ a\\ right\\ sided\\ hemiparesis\\ with\\ strengths\\ of\\ 2\\/5\\ in\\ his\\ right\\ lower\\ extremity\\ and\\ 3\\/5\\ in\\ the\\ right\\ upper\\ extremity\\.\\ he\\ was\\ hyperreflexic\\ right\\ greater\\ than\\ left\\,\\ had\\ right\\ sided\\ spasticity\\,\\ and\\ a\\ right\\ babinski\\ present\\ with\\ clonus\\ in\\ the\\ ankle\\.\\ he\\ also\\ had\\ decreased\\ sensation\\ to\\ light\\ touch\\ throughout\\ his\\ right\\ side\\ including\\ his\\ face\\.\ \(0\)\
\-\ this\\ patient\\ received\\ a\\ six\\ week\\ course\\ or\\ radiation\\ and\\ will\\ start\\ a\\ phase\\ 2\\ clinical\\ chemotherapy\\ trial\\ at\\ the\\ nih\\.\\ he\\ was\\ also\\ started\\ on\\ seizure\\ prophylaxis\\ and\\ pain\\ medication\\.\ \(0\)\
\-\ solitary\\ deep\\ lesion\\ with\\ mild\\ midline\\ shift\\ and\\ patchy\\ enhancement\\.\\ \\ abnormal\\ white\\ matter\\ signal\\ in\\ the\\ right\\ hemisphere\\ suggesting\\ tumor\\ extension\\ across\\ the\\ corpus\\ callosum\\.\ \(0\)\
\-\ brain\\ biopsy\\ confirmed\\ glioblastoma\\ multiforme\\.\ \(0\)\
\-\ \\<li\\>astrocytoma\\ \\-\\ anaplastic\\ \\(usually\\ does\\ not\\ show\\ \\'cystic\\'\\ or\\ necrotic\\ area\\)\ \(0\)\
\-\ \\<li\\>glioblastoma\\ multiforme\\ \\(usually\\ brighter\\ enhancement\\)\ \(0\)\
\-\ \\<li\\>primary\\ cns\\ lymphoma\\ \\(usually\\ lower\\ signal\\ on\\ t2w\\)\ \(0\)\
\-\ \\<li\\>tumefactive\\ demyelination\\ \\(usually\\ does\\ not\\ show\\ edema\\ like\\ this\\)\ \(0\)\
\-\ this\\ patient\\ presented\\ with\\ 3\\ weeks\\ of\\ progressive\\ weakness\\ in\\ right\\ upper\\ and\\ lower\\ extremities\\.\ \(0\)\
\-\ gliomas\\ are\\ graded\\ on\\ the\\ most\\ aggressive\\ histology\\.\\ \\ a\\ small\\ region\\ of\\ gbm\\ may\\ arise\\ or\\ coexist\\ within\\ larger\\ areas\\ of\\ anaplastic\\ astrocytoma\\.\\ \\ gbm\\ usually\\ presents\\ in\\ older\\ patients\\ \\(typically\\ \\>40\\ yrs\\.\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.07433205790898259\ \(0\)\
\-\ \\>\\:\\ 0\\.057942194176909476\ \(0\)\
\-\ \\<\\:\\ 0\\.05384596779594761\ \(0\)\
\-\ usually\\:\\ 0\\.05295771946666855\ \(0\)\
\-\ anaplastic\\:\\ 0\\.04393086709780696\ \(0\)\
\-\ gbm\\:\\ 0\\.04125974129202397\ \(0\)\
\-\ multiforme\\:\\ 0\\.0405336393653587\ \(0\)\
\-\ his\\:\\ 0\\.04021043310443971\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.03840526171259745\ \(0\)\
\-\ \\'cystic\\:\\ 0\\.03598170785292449\ \(0\)\
\-\ coexist\\:\\ 0\\.03315253568737369\ \(0\)\
\-\ right\\:\\ 0\\.03312116482446429\ \(0\)\
\-\ hyperreflexic\\:\\ 0\\.03032336352182289\ \(0\)\
\-\ brighter\\:\\ 0\\.03032336352182289\ \(0\)\
\-\ he\\:\\ 0\\.029194130718771666\ \(0\)\
\-\ spasticity\\:\\ 0\\.027494191356272093\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.027088573050394256\ \(0\)\
\-\ nih\\:\\ 0\\.026583401350907972\ \(0\)\
\-\ 2\\/5\\:\\ 0\\.025839231731340808\ \(0\)\
\-\ sided\\:\\ 0\\.025792053984870576\ \(0\)\
\-\ extremity\\:\\ 0\\.025511501792999495\ \(0\)\
\-\ strengths\\:\\ 0\\.025210045283066286\ \(0\)\
\-\ babinski\\:\\ 0\\.024928441725976688\ \(0\)\
\-\ clonus\\:\\ 0\\.024928441725976688\ \(0\)\
\-\ 3\\/5\\:\\ 0\\.024665019190721296\ \(0\)\
\-\ start\\:\\ 0\\.024184272106409527\ \(0\)\
\-\ does\\:\\ 0\\.02380098832966536\ \(0\)\
\-\ lower\\:\\ 0\\.023533004930986073\ \(0\)\
\-\ demyelination\\:\\ 0\\.023183772277703466\ \(0\)\
\-\ gliomas\\:\\ 0\\.02301005956579001\ \(0\)\
\-\ tumefactive\\:\\ 0\\.022529312481478242\ \(0\)\
\-\ graded\\:\\ 0\\.02238087311751549\ \(0\)\
\-\ yrs\\:\\ 0\\.02209926956042589\ \(0\)\
\-\ trial\\:\\ 0\\.02196543354890348\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.021835847025170496\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.021710248418367422\ \(0\)\
\-\ show\\:\\ 0\\.021413517832584703\ \(0\)\
\-\ fully\\:\\ 0\\.021134417405061685\ \(0\)\
\-\ histology\\:\\ 0\\.020725913492584205\ \(0\)\
\-\ t2w\\:\\ 0\\.01955170095196469\ \(0\)\
\-\ necrotic\\:\\ 0\\.019070953867652923\ \(0\)\
\-\ touch\\:\\ 0\\.018819697161532787\ \(0\)\
\-\ patchy\\:\\ 0\\.018699640487221385\ \(0\)\
\-\ enhancement\\:\\ 0\\.018697867478555397\ \(0\)\
\-\ across\\:\\ 0\\.01864091094660057\ \(0\)\
\-\ signal\\:\\ 0\\.01839244351243085\ \(0\)\
\-\ callosum\\:\\ 0\\.017896741327033405\ \(0\)\
\-\ cns\\:\\ 0\\.017848437418270132\ \(0\)\
\-\ hemisphere\\:\\ 0\\.017753511450252713\ \(0\)\
\-\ \\'\\:\\ 0\\.01770686371219711\ \(0\)\
\-\ medication\\:\\ 0\\.017570036397753667\ \(0\)\
\-\ older\\:\\ 0\\.017570036397753667\ \(0\)\
\-\ alert\\:\\ 0\\.017394455234146768\ \(0\)\
\-\ solitary\\:\\ 0\\.017309418144747412\ \(0\)\
\-\ arise\\:\\ 0\\.017267554878758883\ \(0\)\
\-\ corpus\\:\\ 0\\.017185094848891455\ \(0\)\
\-\ six\\:\\ 0\\.017144481253572406\ \(0\)\
\-\ oriented\\:\\ 0\\.017104267798702968\ \(0\)\
\-\ face\\:\\ 0\\.017104267798702968\ \(0\)\
\-\ aggressive\\:\\ 0\\.01706444667647699\ \(0\)\
\-\ suggesting\\:\\ 0\\.016947262570834416\ \(0\)\
\-\ upper\\:\\ 0\\.016833310247907907\ \(0\)\
\-\ larger\\:\\ 0\\.01679607370683299\ \(0\)\
\-\ ankle\\:\\ 0\\.01661463794123775\ \(0\)\
\-\ shift\\:\\ 0\\.016544263221096908\ \(0\)\
\-\ phase\\:\\ 0\\.01640705256477452\ \(0\)\
\-\ light\\:\\ 0\\.016274304843527338\ \(0\)\
\-\ received\\:\\ 0\\.01620951566329758\ \(0\)\
\-\ like\\:\\ 0\\.016145738855529904\ \(0\)\
\-\ sensation\\:\\ 0\\.01602109916630508\ \(0\)\
\-\ started\\:\\ 0\\.015557437216412406\ \(0\)\
\-\ seizure\\:\\ 0\\.015422717638991305\ \(0\)\
\-\ neurological\\:\\ 0\\.015091937189998954\ \(0\)\
\-\ had\\:\\ 0\\.015051835259107823\ \(0\)\
\-\ \\(\\:\\ 0\\.01474207604579307\ \(0\)\
\-\ 40\\:\\ 0\\.014674133056686424\ \(0\)\
\-\ \\)\\:\\ 0\\.014561993716598063\ \(0\)\
\-\ deep\\:\\ 0\\.014118090405283616\ \(0\)\
\-\ progressive\\:\\ 0\\.01378546577568695\ \(0\)\
\-\ also\\:\\ 0\\.013751996683021645\ \(0\)\
\-\ matter\\:\\ 0\\.01373257130775836\ \(0\)\
\-\ extremities\\:\\ 0\\.013680353546697504\ \(0\)\
\-\ midline\\:\\ 0\\.013494408519749066\ \(0\)\
\-\ course\\:\\ 0\\.01316135283043119\ \(0\)\
\-\ confirmed\\:\\ 0\\.013115916747293052\ \(0\)\
\-\ greater\\:\\ 0\\.013100883092532658\ \(0\)\
\-\ throughout\\:\\ 0\\.013056111535918069\ \(0\)\
\-\ weakness\\:\\ 0\\.01295351572664647\ \(0\)\
\-\ including\\:\\ 0\\.012593545473440507\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.012501819531187206\ \(0\)\
\-\ extension\\:\\ 0\\.012450315596659812\ \(0\)\
\-\ biopsy\\:\\ 0\\.012374258129129637\ \(0\)\
\-\ typically\\:\\ 0\\.012311941916350908\ \(0\)\
\-\ or\\:\\ 0\\.012263543864861724\ \(0\)\
\-\ side\\:\\ 0\\.012083455109241107\ \(0\)\
\-\ week\\:\\ 0\\.011844960891135625\ \(0\)\
\-\ this\\:\\ 0\\.01176902710180571\ \(0\)\
\-\ areas\\:\\ 0\\.011736110903045171\ \(0\)\
\-\ white\\:\\ 0\\.011567772296783747\ \(0\)\
\-\ radiation\\:\\ 0\\.011445923467601374\ \(0\)\
\-\ revealed\\:\\ 0\\.01119377097904528\ \(0\)\
\-\ area\\:\\ 0\\.011027903037282724\ \(0\)\
\-\ will\\:\\ 0\\.010912167421955683\ \(0\)\
\-\ clinical\\:\\ 0\\.010731876734963284\ \(0\)\
\-\ brain\\:\\ 0\\.010495312340011274\ \(0\)\
\-\ patient\\:\\ 0\\.01048888078673128\ \(0\)\
\-\ decreased\\:\\ 0\\.010370434296834938\ \(0\)\
\-\ primary\\:\\ 0\\.010332180664880394\ \(0\)\
\-\ in\\:\\ 0\\.01031993216670012\ \(0\)\
\-\ not\\:\\ 0\\.010080152422383146\ \(0\)\
\-\ lymphoma\\:\\ 0\\.009968157691385657\ \(0\)\
\-\ abnormal\\:\\ 0\\.009947315266591476\ \(0\)\
\-\ weeks\\:\\ 0\\.00989909288531081\ \(0\)\
\-\ edema\\:\\ 0\\.009864993834413433\ \(0\)\
\-\ region\\:\\ 0\\.009851433580568624\ \(0\)\
\-\ presented\\:\\ 0\\.009507582183764936\ \(0\)\
\-\ mild\\:\\ 0\\.009184707975229132\ \(0\)\
\-\ than\\:\\ 0\\.009138974918033772\ \(0\)\
\-\ patients\\:\\ 0\\.009026835099453168\ \(0\)\
\-\ on\\:\\ 0\\.008863971579984833\ \(0\)\
\-\ 3\\:\\ 0\\.008167247047781795\ \(0\)\
\-\ tumor\\:\\ 0\\.008131560414738006\ \(0\)\
\-\ a\\:\\ 0\\.008093873506502066\ \(0\)\
\-\ was\\:\\ 0\\.008067571609907648\ \(0\)\
\-\ most\\:\\ 0\\.008052388333583984\ \(0\)\
\-\ small\\:\\ 0\\.00803500116073926\ \(0\)\
\-\ present\\:\\ 0\\.007877586750741555\ \(0\)\
\-\ exam\\:\\ 0\\.007662179346732809\ \(0\)\
\-\ may\\:\\ 0\\.007650319873053567\ \(0\)\
\-\ 2\\:\\ 0\\.00751063059800223\ \(0\)\
\-\ \\-\\:\\ 0\\.0074764426886055665\ \(0\)\
\-\ presents\\:\\ 0\\.007125078757175208\ \(0\)\
\-\ lesion\\:\\ 0\\.0071043070448998154\ \(0\)\
\-\ within\\:\\ 0\\.006653597585249313\ \(0\)\
\-\ and\\:\\ 0\\.005143114449491956\ \(0\)\
\-\ are\\:\\ 0\\.004754587234814702\ \(0\)\
\-\ at\\:\\ 0\\.004725563889108706\ \(0\)\
\-\ pain\\:\\ 0\\.004259625173594836\ \(0\)\
\-\ left\\:\\ 0\\.003902470486828224\ \(0\)\
\-\ the\\:\\ 0\\.00338569676825206\ \(0\)\
\-\ \\,\\:\\ 0\\.002209878085855407\ \(0\)\
\-\ with\\:\\ 0\\.0019102722626920775\ \(0\)\
\-\ of\\:\\ 0\\.0019021028701712399\ \(0\)\
\-\ \\.\\:\\ 0\\.0018836488541449042\ \(0\)\
\-\ to\\:\\ 0\\.0017431351365019849\ \(0\)\
